Antidiarrheal Drugs Market – Recent Study including Growth Factors, Applications, Regional Analysis, Key Players and Forecasts to 2025

The global Antidiarrheal Drugs market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Antidiarrheal Drugs market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Browse Full Report:

The global Antidiarrheal Drugs market is segregated on the basis of Application as Adults and Children. Based on Type the global Antidiarrheal Drugs market is segmented in OTC Drugs and Prescription Drugs.

The Global Antidiarrheal Drugs market is expected to exceed more than US$ 59.8 Billion by 2024 at a CAGR of 4.9% in the given forecast period.

The increasing incidence of diarrhea across the globe is the primary growth driver for this market. Globally, around 2 billion cases of diarrheic disease occur each year. Diarrhea presents the next risk for people higher than 65 years recent and youngsters under five years. The increasing incidence of the diarrheal disease is creating a demand for Antidiarrheal Drugs, thereby, leading to market growth.

Antidiarrheal drugs are used to treat abrupt diarrhea and possess the mechanism of slowing down the movement of the gut and helps to diminish the number of bowel movements and also make the stools less watery. Distinct causes of diarrhea can be a virus such as a rotavirus, hepatitis, a bacterium such as E.coli, Shigella, and parasites causing amoebiasis and giardiasis. Majority of the events of diarrhea are recognized to be concluded with simple dietary modifications and may not require treatment, however, in certain cases of severe diarrhea, laboratory assessment is requisite which includes blood tests, and stool specimen evaluation to analyze the type of diarrhea.

Competitive Rivalry

GlaxoSmithKline, Proctor & Gamble, Pfizer, Actelion, Perrigo, Lupin, Glenmark Pharmaceuticals, Sanofi Aventis, Merck & Co., Novartis, and others are among the major players in the global Antidiarrheal Drugs market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Antidiarrheal Drugs Market has been segmented as below:

Antidiarrheal Drugs Market, By Application

  • Adults
  • Children

Antidiarrheal Drugs Market, By Type

  • OTC Drugs
  • Prescription Drugs

Antidiarrheal Drugs Market, By Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Antidiarrheal Drugs Market, By Company

  • GlaxoSmithKline
  • Proctor & Gamble
  • Pfizer
  • Actelion
  • Perrigo
  • Lupin
  • Glenmark Pharmaceuticals
  • Sanofi Aventis
  • Merck & Co.
  • Novartis

The report covers:

  • Global Antidiarrheal Drugs  market sizes from 2015 to 2024, along with CAGR for 2018-2024
  • Market size comparison for 2017 vs 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024
  • Global Antidiarrheal Drugs  market trends, covering comprehensive range of consumer trends & manufacturer trends
  • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Antidiarrheal Drugs  market
  • Major market opportunities and challenges in forecast timeframe to be focused
  • Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
  • Comprehensive company profiles of the key industry players

Report Scope:

The global Antidiarrheal Drugs market report scope includes detailed study covering underlying factors influencing the industry trends.

The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.

The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Antidiarrheal Drugs market share. Major industry players with significant revenue share include GlaxoSmithKline, Proctor & Gamble, Pfizer, Actelion, Perrigo, Lupin, Glenmark Pharmaceuticals, Sanofi Aventis, Merck & Co., Novartis, and others.

Reasons to Buy this Report:

  • Gain detailed insights on the Antidiarrheal Drugs  industry trends
  • Find complete analysis on the market status
  • Identify the Antidiarrheal Drugs  market opportunities and growth segments
  • Analyze competitive dynamics by evaluating business segments & product portfolios
  • Facilitate strategy planning and industry dynamics to enhance decision making

Request Sample Report from here:

Table of Contents:

  1. Introduction
    1.1 Key Insights
    1.2 Report Overview
    1.3 Markets Covered
    1.4 Stakeholders
  2. Research Methodology
    2.1 Research Scope
    2.2 Market Research Process
    2.3 Research Data Analysis
    2.4.1 Secondary Research
    2.4.2 Primary Research
    2.4.3 Models for Estimation
    2.5 Market Size Estimation
    2.5.1 Bottom-Up Approach – Segmental Market Analysis
    2.5.2 Top-Down Approach – Parent Market Analysis
  3. Executive Summary
  4. Market Overview
    4.1 Introduction
    4.2.1 Drivers
    4.2.2 Restraints
    4.2.3 Opportunities
    4.2.4 Challenges
    4.2 Porter’s Five Force Analysis
  5. Antidiarrheal Drugs Market, By Application
  6. Antidiarrheal Drugs Market, By Type
  7. Antidiarrheal Drugs Market, By Geography
  8. Competitive Insights
    8.1 Key Insights
    8.2 Company Market Share Analysis
    8.3 Strategic Outlook
    8.3.1 Mergers & Acquisitions
    8.3.2 New Product Development
    8.3.3 Portfolio/Production Capacity Expansions
    8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
    8.3.5 Others
  9. Company Profiles
    9.1 GlaxoSmithKline
    9.1.1 Company Overview
    9.1.2 Product/Service Landscape
    9.1.3 Financial Overview
    9.1.4 Recent Developments
    9.2 Proctor & Gamble
    9.2.1 Company Overview
    9.2.2 Product/Service Landscape
    9.2.3 Financial Overview
    9.2.4 Recent Developments
    9.3 Pfizer
    9.3.1 Company Overview
    9.3.2 Product/Service Landscape
    9.3.3 Financial Overview
    9.3.4 Recent Developments
    9.4 Actelion
    9.4.1 Company Overview
    9.4.2 Product/Service Landscape
    9.4.3 Financial Overview
    9.4.4 Recent Developments
    9.5 Perrigo
    9.5.1 Company Overview
    9.5.2 Product/Service Landscape
    9.5.3 Financial Overview
    9.5.4 Recent Developments
    9.6 Lupin
    9.6.1 Company Overview
    9.6.2 Product/Service Landscape
    9.6.3 Financial Overview
    9.6.4 Recent Developments
    9.7 Glenmark Pharmaceuticals
    9.7.1 Company Overview
    9.7.2 Product/Service Landscape
    9.7.3 Financial Overview
    9.7.4 Recent Developments
    9.8 Sanofi Aventis
    9.8.1 Company Overview
    9.8.2 Product/Service Landscape
    9.8.3 Financial Overview
    9.8.4 Recent Developments
    9.9 Merck & Co.
    9.9.1 Company Overview
    9.9.2 Product/Service Landscape
    9.9.3 Financial Overview
    9.9.4 Recent Developments
    9.10 Novartis
    9.10.1 Company Overview
    9.10.2 Product/Service Landscape
    9.10.3 Financial Overview
    9.10.4 Recent Developments

Other Related Market Research Reports:

Macrolide Drugs Market 2019 Demand, Size, Growth Research Report by 2024 – Market Research Engine


Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay


Phone: +1-855-984-1862

Country: United States